Literature DB >> 19344462

Preferential priming of alloreactive T cells with indirect reactivity.

T V Brennan1, A Jaigirdar, V Hoang, T Hayden, F-C Liu, H Zaid, C K Chang, R P Bucy, Q Tang, S-M Kang.   

Abstract

The relative contributions of the direct and indirect pathways in alloimmune responses have not been fully elucidated. We report a novel murine TCR transgenic system that can simultaneously track the CD4-direct (CD4-d), CD4-indirect (CD4-i) and CD8-direct (CD8-d) pathways after transplantation. Using this system, we have observed a profoundly greater proliferation of CD4-i T cells relative to CD4-d and CD8-d T cells after transplantation. Furthermore, a much larger proportion of CD4-i T cells attain an effector phenotype. We also analyzed endogenous, wild-type T cells using enzyme-linked immunospot analysis. In naïve mice, T cells with indirect reactivity were undetectable, but T cells with direct reactivity were abundant. However, 10 days after skin or heterotopic heart transplantation, CD4-i T cells comprised approximately 10% of the CD4+ response. Consistent with increased priming of the CD4-i pathway, we observed that the CD4-i T cells were further enriched in the effector cells migrating to the allograft and in memory-like T cells persisting after rejection. Thus, priming of the CD4-i pathway is favored after transplantation, allowing a rare population to rapidly become a major component of the CD4+ T-cell response in acute allograft rejection. The generalizability of this observation to other models remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344462      PMCID: PMC5990255          DOI: 10.1111/j.1600-6143.2009.02578.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  36 in total

1.  Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.

Authors:  H Gudmundsdottir; A D Wells; L A Turka
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  Allorecognition.

Authors:  N J Rogers; R I Lechler
Journal:  Am J Transplant       Date:  2001-07       Impact factor: 8.086

3.  Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition.

Authors:  Angela Montecalvo; William J Shufesky; Donna Beer Stolz; Mara G Sullivan; Zhiliang Wang; Sherrie J Divito; Glenn D Papworth; Simon C Watkins; Paul D Robbins; Adriana T Larregina; Adrian E Morelli
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

4.  The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

Authors:  H Auchincloss; R Lee; S Shea; J S Markowitz; M J Grusby; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo.

Authors:  Yifa Chen; Yilmaz Demir; Anna Valujskikh; Peter S Heeger
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

6.  Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.

Authors:  G Benichou; A Valujskikh; P S Heeger
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

7.  Alloantibody production is regulated by CD4+ T cells' alloreactive pathway, rather than precursor frequency or Th1/Th2 differentiation.

Authors:  Dominike Sauvé; Myriam Baratin; Caroline Leduc; Karina Bonin; Claude Daniel
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

8.  Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.

Authors:  R S Lee; M J Grusby; L H Glimcher; H J Winn; H Auchincloss
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

Review 10.  Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.

Authors:  L A Smyth; B Afzali; J Tsang; G Lombardi; R I Lechler
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

View more
  27 in total

Review 1.  Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.

Authors:  Julie B Sneddon; Qizhi Tang; Peter Stock; Jeffrey A Bluestone; Shuvo Roy; Tejal Desai; Matthias Hebrok
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

Review 2.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

3.  Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.

Authors:  Todd V Brennan; Qizhi Tang; Feng-Chun Liu; Vunghi Hoang; Mingying Bi; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Surg Res       Date:  2011-04-05       Impact factor: 2.192

4.  Assessment of Immune Isolation of Allogeneic Mouse Pancreatic Progenitor Cells by a Macroencapsulation Device.

Authors:  Gaetano Faleo; Karim Lee; Vinh Nguyen; Qizhi Tang
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

Review 5.  Antigen Presentation in Transplantation.

Authors:  Maria-Luisa Alegre; Fadi G Lakkis; Adrian E Morelli
Journal:  Trends Immunol       Date:  2016-10-12       Impact factor: 16.687

6.  Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

Authors:  A Gaughan; J Wang; R P Pelletier; T Nadasdy; S Brodsky; S Roy; M Lodder; D Bobek; S Mofatt-Bruce; R L Fairchild; M L Henry; G A Hadley
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

7.  Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Authors:  K Lee; V Nguyen; K-M Lee; S-M Kang; Q Tang
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

8.  Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.

Authors:  Cavit D Kant; Yoshinobu Akiyama; Katsunori Tanaka; Susan Shea; Sarah E Connolly; Sharon Germana; Henry J Winn; Christian LeGuern; Georges Tocco; Gilles Benichou
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

Review 9.  Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms.

Authors:  Christine M Lin; Ronald G Gill
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

10.  Donor dendritic cell-derived exosomes promote allograft-targeting immune response.

Authors:  Quan Liu; Darling M Rojas-Canales; Sherrie J Divito; William J Shufesky; Donna Beer Stolz; Geza Erdos; Mara L G Sullivan; Gregory A Gibson; Simon C Watkins; Adriana T Larregina; Adrian E Morelli
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.